Premium
Melatonin as a candidate compound for neuroprotection in amyotrophic lateral sclerosis (ALS): high tolerability of daily oral melatonin administration in ALS patients
Author(s) -
Jacob Sonja,
Poeggeler Burkhard,
Weishaupt Jochen H.,
Sirén AnnaLeena,
Hardeland Rüdiger,
Bähr Mathias,
Ehrenreich Hannelore
Publication year - 2002
Publication title -
journal of pineal research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.881
H-Index - 131
eISSN - 1600-079X
pISSN - 0742-3098
DOI - 10.1034/j.1600-079x.2002.02943.x
Subject(s) - tolerability , melatonin , medicine , psychology , pharmacology , adverse effect